Efficacy and safety of midostaurin in patients with advanced systemic mastocytosis: 10-year median follow-up of a phase II trial

DeAngelo DJ, George TI, Hirshberg B, et al.

Leukemia · 2018

Grade Bcohort
DOI ↗PubMed ↗

Key Findings

  • ●Long-term midostaurin efficacy confirmed with 10-year median follow-up

Referenced in (1 disease)

Systemic Mastocytosis
ID: pmid-28744009DOI: 10.1038/leu.2017.234PMID: 28744009